Skip to Main Content

Author Details

Rachel H Giles
University Medical Center Utrecht
1993
149
54
PMIDPaper TitleJournal TitlePublished Year
36253306A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel.Eur Urol2023
37636213A protocol for the development of core outcome sets for effectiveness trials and clinical audits in renal cell cancer (R-COS).BJUI Compass2023
36511268The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma.Eur Urol2023
36435661European Association of Urology Guidelines Panel on Renal Cell Carcinoma Update on the New World Health Organization Classification of Kidney Tumours 2022: The Urologist's Point of View.Eur Urol2023
36373660CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase.Nucleic Acids Res2023
34344571Patient-centered care can be improved by joint meetings between cancer patient group leaders and health care providers.Patient Educ Couns2022
35708940An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma.CA Cancer J Clin2022
35475554Large scale genotype- and phenotype-driven machine learning in Von Hippel-Lindau disease.Hum Mutat2022
35346519European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update.Eur Urol2022
35579632Multidisciplinary integrated care pathway for von Hippel-Lindau disease.Cancer2022
35624339A community approach to the cancer-variant-interpretation bottleneck.Nat Cancer2022
36578462A Systematic Review of Heterogeneity in Outcome Definition and Reporting in Localised Renal Cancer.Eur Urol Open Sci2022
36169335Reply to "von Hippel-Lindau disease integrated care pathway: Centralizing, expanding specialists' theatre, and measuring improvement".Cancer2022
349208972021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma.Eur Urol2022
35243386Patient-reported Experience of Diagnosis, Management, and Burden of Renal Cell Carcinomas: Results from a Global Patient Survey in 43 Countries.Eur Urol Open Sci2022
33357997Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma.Eur Urol2021
33512331Diagnostic and management strategies for pNETs in Von Hippel-Lindau: a systematic review.Endocr Relat Cancer2021
35059546Is There a Role for Biomarkers in Surveillance of Pancreatic Neuroendocrine Neoplasms in Von Hippel-Lindau Disease?J Endocr Soc2021
34074559The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibitor-based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care.Eur Urol2021
31171501Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel.Eur Urol Oncol2020
32061435Transgenic zebrafish modeling low-molecular-weight proteinuria and lysosomal storage diseases.Kidney Int2020
31673890Clear cell chondrosarcoma in Von Hippel-Lindau disease.Fam Cancer2020
33131181Loss of CBY1 results in a ciliopathy characterized by features of Joubert syndrome.Hum Mutat2020
32587360Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events.Br J Cancer2020
32245655Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel.Eur Urol Oncol2020
32325871Control of Angiogenesis via a VHL/miR-212/132 Axis.Cells2020
30528378Imaging in Suspected Renal-Cell Carcinoma: Systematic Review.Clin Genitourin Cancer2019
30071318Changes in the urinary extracellular vesicle proteome are associated with nephronophthisis-related ciliopathies.J Proteomics2019
30006056Characterization of VHL promoter variants in patients suspected of Von Hippel-Lindau disease.Eur J Med Genet2019
31412255A CEP104-CSPP1 Complex Is Required for Formation of Primary Cilia Competent in Hedgehog Signaling.Cell Rep2019
31368132Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease patients.Clin Genet2019
31095607CiliaCarta: An integrated and validated compendium of ciliary genes.PLoS One2019
31151678Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma.Eur Urol2019
30803729European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.Eur Urol2019
31087189The incidence of consecutive manifestations in Von Hippel-Lindau disease.Fam Cancer2019
30388224Loss-of-function mutations in KIF14 cause severe microcephaly and kidney development defects in humans and zebrafish.Hum Mol Genet2019
29342457The von Hippel-Lindau Gene Is Required to Maintain Renal Proximal Tubule and Glomerulus Integrity in Zebrafish Larvae.Nephron2018
29974258Clinical and genetic analyses of a Dutch cohort of 40 patients with a nephronophthisis-related ciliopathy.Pediatr Nephrol2018
30236512The first prospective trial for von Hippel-Lindau disease: pazopanib.Lancet Oncol2018
29959317Targeted deletion of the AAA-ATPase Ruvbl1 in mice disrupts ciliary integrity and causes renal disease and hydrocephalus.Exp Mol Med2018
30177291Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell Carcinoma.Eur Urol2018
29904105An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma.Nat Rev Urol2018
30201510A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition: The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human Use Does not Change Evidence-based Guideline Recommendations.Eur Urol2018
29868523The KOUNCIL Consortium: From Genetic Defects to Therapeutic Development for Nephronophthisis.Front Pediatr2018
29784193Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis.Eur Urol2018
29228333DNAAF1 links heart laterality with the AAA+ ATPase RUVBL1 and ciliary intraflagellar transport.Hum Mol Genet2018
29080283TCF21 hypermethylation regulates renal tumor cell clonogenic proliferation and migration.Mol Oncol2018
29223605Updated European Association of Urology Guidelines: Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer.Eur Urol2018
29323117Impaired autophagy bridges lysosomal storage disease and epithelial dysfunction in the kidney.Nat Commun2018
27986369Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma.Eur Urol2017
  • 1 - 50 of 149

Recommended Authors

Tuo Zhang
Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 3
Rama Rao Damerla
Kasturba Medical College, Manipal Academy of Higher Education (MAHE)
Career Start Year 2010
Number of shared co-authors 3
Ignaty Leshchiner
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2008
Number of shared co-authors 3
Julien Masliah-Planchon
Curie Institute Hospital Group
Career Start Year 2008
Number of shared co-authors 3
Nelly M Cruz
Memorial Sloan Kettering Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Sudheer Kumar Gara
National Cancer Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 0
Feng Chen
Washington University in St Louis
Career Start Year 2004
Number of shared co-authors 4
Angshumoy Roy
Texas Children's Hospital and Baylor College of Medicine
Career Start Year 2004
Number of shared co-authors 15
Thomas J Mitchell
University at Albany, State University of New York
Career Start Year 2004
Number of shared co-authors 3
Douglas R Stewart
Clinical Genetics Branch, National Cancer Institute
Career Start Year 2003
Number of shared co-authors 3
Han Si
Hubei Engineering Research Center for Bio-enzyme Catalysis, Hubei University
Career Start Year 2003
Number of shared co-authors 0
Eric W Klee
Mayo Clinic College of Medicine and Science
Career Start Year 2001
Number of shared co-authors 8
Kevin R Brown
College Street, University of Toronto
Career Start Year 2000
Number of shared co-authors 1
Jan Koster
Amsterdam University Medical Centers location AMC
Career Start Year 1999
Number of shared co-authors 15
Shashikant Kulkarni
Centene Center for Health Transformation, Centene Corporation
Career Start Year 1998
Number of shared co-authors 30
Alex Kentsis
Memorial Sloan-Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 1
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 0
Sandra Burkett
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 0
Bryan Lo
The Ottawa Hospital/University of Ottawa
Career Start Year 1994
Number of shared co-authors 4
Zhengping Zhuang
National Cancer Institute, National Institutes of Health
Career Start Year 1994
Number of shared co-authors 3
Samuel Aparicio
University of British Columbia
Career Start Year 1993
Number of shared co-authors 4
Weei-Yuarn Huang
Nova Scotia Health Authority
Career Start Year 1992
Number of shared co-authors 0
Ming-Hui Wei
Yantai Affiliated Hospital of Binzhou Medical University
Career Start Year 1991
Number of shared co-authors 2
Sean M Grimmond
The University of Melbourne
Career Start Year 1990
Number of shared co-authors 4
Sanjay Jain
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 3
Glenn S Cowley
Broad Institute of Harvard and MIT
Career Start Year 1990
Number of shared co-authors 1
Shrikant Mane
Yale School of Medicine
Career Start Year 1989
Number of shared co-authors 14
James F Amatruda
Children's Hospital of Los Angeles
Career Start Year 1988
Number of shared co-authors 1
Katherine L Nathanson
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Career Start Year 1986
Number of shared co-authors 7
David J Adams
Wellcome Sanger Institute
Career Start Year 1980
Number of shared co-authors 7

Collaborators

Emile E Voest
The Netherlands Cancer Institute
Co-authored papers 24
Martijn P Lolkema
Erasmus MC Cancer Institute
Co-authored papers 9
Colin A Johnson
University of Leeds Leeds Institute of Medical Research at St James's
Co-authored papers 8
Friedhelm Hildebrandt
Boston Children's Hospital
Co-authored papers 8
Gert-Jan B van Ommen
Co-authored papers 8
Bert A van der Reijden
Co-authored papers 6
Martijn A Huynen
Radboud University Medical Centre Nijmegen
Co-authored papers 6
Hans Clevers
Princess Maxima Center for Pediatric Oncology
Co-authored papers 5
Teunis J P van Dam
Utrecht University
Co-authored papers 5
Dan Doherty
University of Washington
Co-authored papers 5
Raymond H Kim
Cardiac Genome Clinic, The Hospital for Sick Children
Co-authored papers 5
Heymut Omran
University Hospital Muenster
Co-authored papers 5
Nicholas Katsanis
Northwestern University
Co-authored papers 5
Philip L Beales
UCL Great Ormond Street Institute of Child Health, University College London
Co-authored papers 5
Niven Mehra
Radboud university medical center
Co-authored papers 4
Yasser Salama
University Health Network
Co-authored papers 4
John A Sayer
Translational and Clinical Research Institute, Newcastle University
Co-authored papers 4
Lynzey Kujan
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers 3
Jason Saliba
Washington University in St Louis School of Medicine
Co-authored papers 3
Shawn Levy
HudsonAlpha Institute for Biotechnology
Co-authored papers 3
Lana M Sheta
University of Nevada
Co-authored papers 3
Kirsten M Farncombe
Toronto General Hospital
Co-authored papers 3
Kilannin Krysiak
Washington University School of Medicine
Co-authored papers 3
Peter K Jackson
Stanford University School of Medicine, Center for Clinical Sciences Research
Co-authored papers 3
Toni K Choueiri
Dana-Farber Cancer Institute
Co-authored papers 3
Obi L Griffith
Washington University
Co-authored papers 3
Malachi Griffith
Washington University
Co-authored papers 3
Arpad M Danos
McDonnell Genome Institute, Washington University in St Louis School of Medicine
Co-authored papers 3
Paul J van Diest
University Medical Center Utrecht
Co-authored papers 3
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers 2
Release 1.2